par nepar mogu da urade kao nekad sa tablicama u doba SFRJKinderLad wrote:Papa Lazarou wrote:Koliko čitam i slušam iz više izvora - naredba o karantinu penzionera ne funkcioniše.
Nemam sta da citam, video sam ih bar 5 na ulici. Moraju ljudima da ostave neki period od tipa dva sata, ili da po zadnjem broju JMBG podele kojim danima neko moze da izadje na 2-3 sata. I da pomere polic. cas na 22h, nema sanse da se u 20h isprazne ulice. Ili bar da kazu - sedite naredne tri nedelje da vidimo ima li efekta
U.S. Virus Plan Anticipates 18-Month Pandemic and Widespread Shortages
The 100-page federal plan laid out a grim prognosis and outlined a response that would activate agencies across the government.
WASHINGTON — A federal government plan to combat the coronavirus warned policymakers last week that a pandemic “will last 18 months or longer” and could include “multiple waves,” resulting in widespread shortages that would strain consumers and the nation’s health care system.
The 100-page plan, dated Friday, the same day President Trump declared a national emergency, laid out a grim prognosis for the spread of the virus and outlined a response that would activate agencies across the government and potentially employ special presidential powers to mobilize the private sector.
Among the “additional key federal decisions” listed among the options for Mr. Trump was invoking the Defense Production Act of 1950, a Korean War-era law that authorizes a president to take extraordinary action to force American industry to ramp up production of critical equipment and supplies such as ventilators, respirators and protective gear for health care workers.
“Shortages of products may occur, impacting health care, emergency services, and other elements of critical infrastructure,” the plan warned. “This includes potentially critical shortages of diagnostics, medical supplies (including PPE and pharmaceuticals), and staffing in some locations.” P.P.E. refers to personal protective equipment.
The plan continued: “State and local governments, as well as critical infrastructure and communications channels, will be stressed and potentially less reliable. These stresses may also increase the challenges of getting updated messages and coordinating guidance to these jurisdictions directly.”
The plan, which was unclassified but marked “For Official Use Only // Not For Public Distribution or Release,” was shared with The New York Times as Mr. Trump escalated his efforts to curb the spread of the virus. After weeks of playing down the seriousness of the pandemic, saying it would miraculously disappear, Mr. Trump began shifting to a more sober tone during a news conference on Friday announcing the national emergency.
Much of the plan is bureaucratic in nature, describing coordination among agencies and actions that in some cases have already been taken, like urging schools to close and large events to be canceled. But its discussion of the Defense Production Act came as lawmakers and others urged Mr. Trump to invoke its powers.
...
https://www.nytimes.com/2020/03/17/us/politics/trump-coronavirus-plan.html?smid=fb-share
Medical authorities in China have said a drug used in Japan to treat new strains of influenza appeared to be effective in coronavirus patients, Japanese media said on Wednesday.
Zhang Xinmin, an official at China’s science and technology ministry, said favipiravir, developed by a subsidiary of Fujifilm, had produced encouraging outcomes in clinical trials in Wuhan and Shenzhen involving 340 patients.
“It has a high degree of safety and is clearly effective in treatment,” Zhang told reporters on Tuesday.
Patients who were given the medicine in Shenzhen turned negative for the virus after a median of four days after becoming positive, compared with a median of 11 days for those who were not treated with the drug, public broadcaster NHK said.
In addition, X-rays confirmed improvements in lung condition in about 91% of the patients who were treated with favipiravir, compared to 62% or those without the drug.
Fujifilm Toyama Chemical, which developed the drug – also known as Avigan – in 2014, has declined to comment on the claims.
Shares in the firm surged on Wednesday following Zhang’s comments, closing the morning up 14.7% at 5,207 yen, having briefly hit their daily limit high of 5,238 yen.
Doctors in Japan are using the same drug in clinical studies on coronavirus patients with mild to moderate symptoms, hoping it will prevent the virus from multiplying in patients.
But a Japanese health ministry source suggested the drug was not as effective in people with more severe symptoms. “We’ve given Avigan to 70 to 80 people, but it doesn’t seem to work that well when the virus has already multiplied,” the source told the Mainichi Shimbun.
The same limitations had been identified in studies involving coronavirus patients using a combination of the HIV antiretrovirals lopinavir and ritonavir, the source added.
Gargantua wrote:developed by a subsidiary of Fujifilm
Ravnatelj mostarske bolnice. pic.twitter.com/FBN47gHr7r
— Ivana Tomić (@tomicivanaa) March 18, 2020
U Istri je umro muškarac koji je bio u samoizolaciji zbog virusa korona, što je i prvi smrtni slučaj u Hrvatskoj.
Imao je blage simptome bolesti, ali mu se u noći na sredu stanje naglo pogoršalo, došlo je do komplikacija i muškarac je umro.
Odbio je da ode u bolnicu iako su lekari to predlagali. Iako još zvanično nije potvrđeno da je korona virus uzrokovao smrt starijeg muškarca, predstavnici Zavoda za javno zdravstvo kažu da je to verovatno prvi smrtni slučaj od posledica korona virusa u Hrvatskoj.
Gargantua wrote:Malo više detalja o onom leku favipiravir:
Medical authorities in China have said a drug used in Japan to treat new strains of influenza appeared to be effective in coronavirus patients, Japanese media said on Wednesday.
Zhang Xinmin, an official at China’s science and technology ministry, said favipiravir, developed by a subsidiary of Fujifilm, had produced encouraging outcomes in clinical trials in Wuhan and Shenzhen involving 340 patients.
“It has a high degree of safety and is clearly effective in treatment,” Zhang told reporters on Tuesday.
Patients who were given the medicine in Shenzhen turned negative for the virus after a median of four days after becoming positive, compared with a median of 11 days for those who were not treated with the drug, public broadcaster NHK said.
In addition, X-rays confirmed improvements in lung condition in about 91% of the patients who were treated with favipiravir, compared to 62% or those without the drug.
Fujifilm Toyama Chemical, which developed the drug – also known as Avigan – in 2014, has declined to comment on the claims.
Shares in the firm surged on Wednesday following Zhang’s comments, closing the morning up 14.7% at 5,207 yen, having briefly hit their daily limit high of 5,238 yen.
Doctors in Japan are using the same drug in clinical studies on coronavirus patients with mild to moderate symptoms, hoping it will prevent the virus from multiplying in patients.
But a Japanese health ministry source suggested the drug was not as effective in people with more severe symptoms. “We’ve given Avigan to 70 to 80 people, but it doesn’t seem to work that well when the virus has already multiplied,” the source told the Mainichi Shimbun.
The same limitations had been identified in studies involving coronavirus patients using a combination of the HIV antiretrovirals lopinavir and ritonavir, the source added.
Say hello to Punk Sanitiser
— BrewDog (@BrewDog) March 18, 2020
To help with the shortages, we have just started working on making hand sanitiser at our distillery in Scotland. We are determined to do everything we can to try and help as many people as possible stay safe.
It's time to keep it clean. pic.twitter.com/1rNoGqdVXF
Nije potvrdjeno da ima veze sa koronom. Covek nije testiran.Gargantua wrote:Sranje
U Istri je umro muškarac koji je bio u samoizolaciji zbog virusa korona, što je i prvi smrtni slučaj u Hrvatskoj.
Imao je blage simptome bolesti, ali mu se u noći na sredu stanje naglo pogoršalo, došlo je do komplikacija i muškarac je umro.
Odbio je da ode u bolnicu iako su lekari to predlagali. Iako još zvanično nije potvrđeno da je korona virus uzrokovao smrt starijeg muškarca, predstavnici Zavoda za javno zdravstvo kažu da je to verovatno prvi smrtni slučaj od posledica korona virusa u Hrvatskoj.
Dambo wrote:Možda je već kačeno - izraelska tajna služba će kroz podatke mobilne telefonije pratiti kretanje zaraženih koronavirusom unazad, kako bi se videlo sa kime su još došli u kontakt.
https://www.timesofisrael.com/knesset-committee-chair-slams-cabinets-phone-tracking-decision-as-power-grab/
Gargantua wrote:... authorizes a president to take extraordinary action to force American industry to ramp up production of critical equipment and supplies such as ventilators, respirators and protective gear for health care workers.
I'm not a fan of reparations for the sins of past generations. But when this is all over, amid the terrible human suffering that is now inevitable, is there not a case for demanding some sort of reparations from the Chinese government? https://t.co/s0FbW2jdPx
— Matt Ridley (@mattwridley) March 16, 2020
Home
by Guest Wed Mar 18, 2020 12:23 pm
